These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
61 related items for PubMed ID: 6638210
21. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats. Toba H, Yoshida M, Tojo C, Nakano A, Oshima Y, Kojima Y, Noda K, Wang J, Kobara M, Nakata T. Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815 [Abstract] [Full Text] [Related]
22. Histometric assessment of renal arterioles during DOCA and post-DOCA hypertension and hydralazine treatment in rats. Vial JH, Boyd GW. J Hypertens; 1989 Mar; 7(3):203-9. PubMed ID: 2708816 [Abstract] [Full Text] [Related]
23. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats. Nishimura M, Ohtsuka K, Sakamoto M, Nanbu A, Takahashi H, Yoshimura M. J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722 [Abstract] [Full Text] [Related]
24. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats. Itoh H, Nakao K, Mukoyama M, Yamada T, Hosoda K, Shirakami G, Morii N, Sugawara A, Saito Y, Shiono S. J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622 [Abstract] [Full Text] [Related]
25. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors. Hirata Y, Suzuki Y, Suzuki E, Hayakawa H, Kimura K, Goto A, Omata M, Minamino N, Kangawa K, Matsuo H. J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160 [Abstract] [Full Text] [Related]
27. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats. Park CG, Leenen FH. J Korean Med Sci; 2001 Oct; 16(5):553-7. PubMed ID: 11641522 [Abstract] [Full Text] [Related]
28. Enhanced induction of gastric carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in deoxycorticosterone acetate-NaCl hypertensive rats and its inhibition by potassium chloride. Tatsuta M, Iishi H, Baba M, Taniguchi H. Cancer Res; 1991 Jun 01; 51(11):2863-6. PubMed ID: 2032226 [Abstract] [Full Text] [Related]
30. [Effects of several beta-blockers and penfluzide, a thiazide diuretic, on the blood pressure, urinary water output and excretion of Na and K in DOCA-saline-induced hypertension in rats]. Sugai T, Nakagawa Y, Takeda K, Imai S. Nihon Yakurigaku Zasshi; 1983 Sep 01; 82(3):181-90. PubMed ID: 6141125 [Abstract] [Full Text] [Related]
31. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. Klanke B, Cordasic N, Hartner A, Schmieder RE, Veelken R, Hilgers KF. Nephrol Dial Transplant; 2008 Nov 01; 23(11):3456-63. PubMed ID: 18515791 [Abstract] [Full Text] [Related]
35. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Silambarasan T, Raja B. Eur J Pharmacol; 2012 Mar 15; 679(1-3):81-9. PubMed ID: 22266490 [Abstract] [Full Text] [Related]
37. Influence of DOCA treatment on administration-time-dependent changes in the effects of furosemide in saline-loaded rats. Fujimura A, Sudoh T, Shiga T, Ohashi K, Ebihara A. Jpn J Pharmacol; 1992 Jun 15; 59(2):209-12. PubMed ID: 1434117 [Abstract] [Full Text] [Related]